Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid

Department of Medicine (I.R.R., G.D.G.), University of Auckland, Auckland 1142, New Zealand; Integrated Information Sciences, Novartis Pharmaceuticals (P.M.), East Hanover, New Jersey 07936; 1st Department of Medicine Semmelweis University (P.L.), H-1085 Budapest, Hungary; and Department of Epidemiology and Biostatistics (D.M.B.), University of California, San Francisco, San Francisco, California 94143